Ceramides as Risk Markers for Future Cardiovascular Events and All-Cause Mortality in Long-standing Type 1 Diabetes.

"the code used for data analysis is available on github: https://github com/asger-w/profil-ceramides ."

"the code used for data analysis is available on github: https://github com/asger-w/profil-ceramides ."

"Duality of Interest. P.R. has received honoraria for consultancy to Steno Diabetes Center Copenhagen from Astellas, Astra Zeneca, Boehringer Ingelheim, Bayer, Merck, Gilead, Novo Nordisk, and Sanofi Aventis. N.T. and S.A.W. are full-time employees of Novo Nordisk A/S. No other potential conflicts of interest relevant to this article were reported."

"Funding. Funding was provided by Steno Diabetes Center Copenhagen, Gentoſte, Denmark. We acknowledge support from Novo Nordisk Foundation grant NNF14OC0013659 “PROTON Personalizing treatment of diabetic nephropathy.”"

"The original study is registered at ClinicalTrials.gov under the identifier NCT01171248; it holds ethical approval from the Danish National Committee on Biomedical Research Ethics, Copenhagen, Denmark (2009-056). The follow-up protocol was approved The Ethics Committee E, Region Hovedstaden, Hillerød, Denmark. Both the original study and the follow-up protocol adhere to principles of the Declaration of Helsinki. Written and informed consent was given by the participants before inclusion in the original study, which included consent for inclusion in a follow-up study."